Pharmaceutical Technology11 天
Cinrebafusp alfa by Pieris Pharmaceuticals for Vulvar Cancer: Likelihood of Approval
Cinrebafusp alfa is under clinical development by Pieris Pharmaceuticals and currently in Phase I for Vulvar Cancer. According to GlobalData, Phase I drugs for Vulvar Cancer have a 94% phase ...
Pharmaceutical Technology11 天
Tivozanib hydrochloride by AVEO Pharmaceuticals for Vulvar Cancer: Likelihood of Approval
Tivozanib hydrochloride is under clinical development by AVEO Pharmaceuticals and currently in Phase II for Vulvar Cancer.